Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Keidanren, Nikkeiren Propose Senior Healthcare System
May 28, 2001
- Snow Brand Milk to Transfer Its Pharma Business to Daiichi
May 21, 2001
- Over 40% of Doctors Recognize Usefulness of Large-scale Trials: Survey
May 21, 2001
- Fujisawa to Transfer Animal Health Business to Schering-Plough
May 21, 2001
- Increasing Number of Firms Try to Obtain Information on Competitors Based on Information Access Law
May 21, 2001
- Shionogi USA Established
May 21, 2001
- REGULATORY NEWS IN BRIEF
May 21, 2001
- Santen Ties Up with PDI for Levofloxacin
May 21, 2001
- JMA to Start Monitoring Medical Facilities' Business Performance
May 21, 2001
- SSP, Nihon Tenganyaku to Jointly Research Antifungal Eye Drop
May 21, 2001
- \240,000 Necessary per Month forNursing Care: Survey Respondents
May 21, 2001
- Kissei Completes Therapeutic Nutritive Food Business Center
May 21, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
May 21, 2001
- Ethical Drugs Achieve 2.5% Growth in FY2000
May 21, 2001
- WORLD NEWS ON BRIEF
May 21, 2001
- Sankyo Stresses Fewer Drug Interactions for Mevalotin
May 21, 2001
- Sanofi-Synthelabo, Organon to Jointly Start PII for Pentasaccharide
May 21, 2001
- Daiichi Applies for Chronic Heart Failure as New Indication for Carvedilol
May 21, 2001
- Nippon BD to Open Lab in Advanced Medical Center in Kobe
May 21, 2001
- Dainippon Licenses Antipsychotic Blonanserin to Almirall
May 21, 2001
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…